newsfilter
← Latest News
GlobeNewswire·

Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results and Provides Corporate Update

~ Company on Track to Submit New Drug Application (NDA) for RECORLEV® (levoketoconazole) to the FDA in the First Quarter of 2021 Following the Reporting of Positive Top-line Data from the LOGICS Study...